Vacancy for Medical Representative by TrueOsis Consultancy

TrueOsis ever since its inception in 2007 has been involved in providing high quality manpower solutions and services. We have been successful in providing consistent and reliable services to our customers who include BFSI, BPOs, IT Industries, Pharma, Private Manufacturing Enterprises and FMCG Companies.
The culture at TrueOsis is based on strong interaction with customers in order to provide complete satisfaction in terms of desired output.

Requirement in New Product Development @ inVentiv Health Clinical

inVentiv Health Clinical, a leader in drug development services, has a global infrastructure, therapeutic expertise, and commitment to quality that is unmatched in the industry. For pharmaceutical, biotechnology, generic drug, and medical device companies of all sizes around the world, inVentiv Health Clinical can help you transform promising ideas into commercial reality.

Opening for Business Development Executive, Area Sales Manager, Sales Officer/ Territory Officer, HR Assistant, Account Assistant @ HLL Lifecare

HLL Lifecare Limited (formerly Hindustan Latex Limited) India’s leading manufacturers and marketers of Contraceptive, Health Care and Pharma products is a Mini Ratna Company under the Ministry of Health & Family Welfare, Govt. of India, with seven manufacturing units and marketing offices throughout the country.


About Author:
Sarabjeet Kaur
M.pharm Lord Shiva College of pharmacy Sirsa
Teaching Assistant Dept of Pharm. Edu. and research, Bhainswal Kalan
BPSMV, Sonipat

Asymmetric hydrogenation is by far the most attractive form of stereoselective synthesis. Using optically pure catalysts, prochiral substrates can be converted to chiral compounds with high selectivity. These catalysts can be completely organic in nature (for example proline 50) or contain a transition metal which coordinates to an organic chiral ligand. In the last decades, considerable progress has been made in the development of metal catalyzed asymmetric transformation based on enantiopure ligands complexed to a transition metal core. However, the identification of suitable asymmetric catalysts still poses one of the most challenging endeavours in contemptory chemistry.